Peptide sequences specific for the hepatic stages of

P. falciparumP. falciparum P. falciparum The present invention relates to an in vitro diagnostic method for malaria in an individual comprising placing a tissue or a biological fluid taken from an individual in contact with a molecule or polypeptide composition, wherein said molecule or polypeptide...

Full description

Saved in:
Bibliographic Details
Main Authors Guerin-Marchand, Claudine, Druilhe, Pierre
Format Patent
LanguageEnglish
Published 21.10.2008
Online AccessGet full text

Cover

Loading…
More Information
Summary:P. falciparumP. falciparum P. falciparum The present invention relates to an in vitro diagnostic method for malaria in an individual comprising placing a tissue or a biological fluid taken from an individual in contact with a molecule or polypeptide composition, wherein said molecule or polypeptide composition comprises one or more peptide sequences bearing all or part of one or more T epitopes of the proteins resulting from the infectious activity of , under conditions allowing an in vitro immunological reaction to occur between said composition and the antibodies that may be present in the tissue or biological fluid, and in vitro detection of the antigen-antibody complexes formed. The invention further relates to a polypeptide comprising at least one T epitope from a liver-stage specific protein produced by and a vaccine composition directed against malaria comprising a molecule having one or more peptide sequences bearing all or part of one or more T epitopes resulting from the infectious activity of in the hepatic cells.